



The Centers for Disease Control and Prevention (CDC) committed a staggering $1.8 billion for the procurement of 20 million pediatric COVID-19 vaccines.
The deal, inked in June 2023, was revealed by Natalie Winters, Co-Host and Executive Editor of Steve Bannon’s War Room. What makes this deal intriguing is the timing – it was preemptively organized, predicting a surge in September.
The CDC conducted a needs assessment in July 2023, which indicated that approximately 16.75 million pediatric COVID-19 vaccines were required.
This figure represented a 15% increase from the vaccine quantities available in contracts awarded in June. However, the CDC did not allow time for open competition, citing compressed timeframes and urgent need as reasons.
This raises questions about the intuition or data that led the CDC to such a well-timed prediction. The agency moved to finalize these contracts before even assessing the exact vaccine needs for September.
The CDC’s own documentation acknowledges the lack of competition in sourcing these vaccines, indicating the compressed timeframe left them with inadequate time to open the contracts for competitive bidding.
The CDC’s decision to increase the maximum ordering quantity on two of its three pediatric COVID-19 vaccine contracts was driven by several factors.
Firstly, the agency had to determine the appropriate funding obligation for each contract in early August 2023 to ensure sufficient funding was available upon the start of ordering in September 2023.
Secondly, the vaccine manufacturers needed to understand how many doses were required for CDC’s programs to incorporate their needs into their planning.
Lastly, CDC’s 64 immunization awardees needed clarity on whether their full needs for pediatric COVID-19 vaccines would be met through CDC’s vaccine programs.
The CDC’s needs assessment established a need for 16.75 million doses of pediatric COVID-19 vaccines, exceeding the number of vaccines available on the contracts as awarded in June 2023 by approximately 15%.
This shortfall could have led to serious consequences, including an increase in preventable illnesses, hospitalizations, and deaths among vulnerable U.S. children.
The timing of this order coincides with reports that the Biden administration is preparing to reinstate comprehensive COVID-19 restrictions, starting with a renewed mask mandate for TSA and airport employees by mid-September.
This information was disclosed by a high-ranking TSA official to Alex Jones of Infowars, who described a recent meeting where TSA management received updated memos and policies on mask requirements.
While the CDC’s preemptive purchase of 20 million pediatric COVID-19 vaccines may seem like a prudent move in the face of a potential surge, it also raises questions about the agency’s decision-making process and the lack of open competition.